Get more replies from employers
Send a job-specific resume in minutes.
Tempus AI, Inc. in Chicago seeks an experienced anatomic pathologist to conduct preliminary pathology review (H&E) for research and clinical specimens, focusing on PD-L1, MMR, and HER2 biomarkers.
You will sign out cases and collaborate with a multidisciplinary team on key biological questions. The role involves assisting the AP Lab Director with CLIA/CAP compliance, proficiency testing, SOP updates, and workflow improvements.
Passionate about precision medicine and advancing the healthcare industry? Recent advancements in underlying technology have finally made it possible for AI to impact clinical care in a meaningful way. Tempus' proprietary platform connects an entire ecosystem of real-world evidence to deliver real-time, actionable insights to physicians, providing critical information about the right treatments for the right patients, at the right time.
Conduct preliminary pathology review (H&E review for specimen adequacy for NGS) for both research and clinical specimens IHC sign out, with a focus on non-22c3 PD-L1 clones, challenging MMR cases and other predictive biomarkers for antibody drug conjugates (i.e. HER2) Collaborate with multi-disciplinary team focused on answering key biological questions and keeping up with TMO (Tempus Molecular Ontology) cohorts Participation in research projects as well as lab innovation projects, i.e. development of digital/remote pathology review, AI initiatives, new assay validation and other algorithms that necessitate Anatomic Pathology input, experience and collaboration Specimen review will be performed on-site at our laboratory in downtown Chicago Assist AP Lab Director with maintaining CLIA/CAP compliance and proficiency testing requirements Assist with handling contractor questions, scheduling and other issues Participate in pathology laboratory coordinator (PLC) education and training, as well as assisting with patient data abstraction as needed Participate in and potentially lead PLC pre-pathology review and pathology review workflow improvements Collaborate in creation and updating of standard operating procedure documentation and working instructions for PLCs and pathologists Generally a M-F role, however the option to work a non-traditional schedule of Tuesdays through Saturdays can be discussed, if preferred
Chicago Pay Range: $240,000-$280,000 The expected salary range above is applicable if the role is performed from Illinois and may vary for other locations (California, Colorado, New York). Actual salary may vary based on qualifications and experience.
Tempus offers a full range of benefits, which may include incentive compensation, restricted stock units, medical and other benefits depending on the position.
We are an equal opportunity employer.
We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.
Tempus was founded in August of 2015 by Eric Lefkofsky, after his wife was diagnosed with Breast Cancer. Shortly after he founded the company in an effort to bring the power of technology and artificial intelligence to cancer care, he convinced Ryan Fukushima to join as the company’s first employee. Ryan and Eric began assembling a world class team, focused on building the first version of a platform capable of ingesting real time healthcare data in an effort to personalize diagnostics. We built the platform for oncology and have expanded it to neuropsychiatry, cardiology, infectious disease (through COVID), and radiology. Despite our rapid growth, our mission remains the same—to help make sure patients are on the right drug at the right time, so they can live longer and healthier lives. We’re looking for people who can change the world. Who question the status quo and don’t shy away from tough problems. For the builders who are never done building and the learners who are never done learning. We’re looking for passionate people with undying curiosity. Those who want to attack one of the most challenging problems mankind has ever faced. Head on.